Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-KDR antibody (Catalog #: AVARP20010_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Alias Symbols: CD309, FLK1, VEGFR, VEGFR2
Protein Interaction Partner: SHC2,VEGFA,VEGFA,VEGFA,VEGFC,ACP1,ANXA5,ATR,BMX,CAV1,CBL,CDH5,COL18A1,CRK,CSF2RB,CTNNB1,DNM2,FIGF,FLT1,FLT4,FRS2,FYN,GNA11,GNAQ,GRB10,GRB2,HSP90AA1,IQGAP1,ITGB3,KDR,NCK1,NRP1,P2RY2,PLCG1,PLCG2,PTPN11,PTPN6,RASA1,SH2D2A,SHB,SHC1,SHC2,SRC,STAT1,SYNGAP1,TIMP3,VEGFA,VEGFC,YES1,ACP1,ANXA5,CBL,CDH5,COL18A1,FIGF,FLT1,GRB10,GRB2,PLCG1,PLXNA1,RASA1,SHB,SHC1,SHC2,VEGFA